Showing 8291-8300 of 18151 results for "".
- Two-Step Screening Strategy Could Reduce Diabetic Heart Failurehttps://reachmd.com/news/two-step-screening-strategy-could-reduce-diabetic-heart-failure/2456722/DALLAS – Jan. 02, 2024 – A two-step screening protocol that combines clinical risk assessment with biomarker testing can more effectively identify which patients with Type 2 diabetes need medication to prevent heart failure, according to a study led by UT Southwest
- AI and Diabetes: Elevating Insulin Dosing and Monitoringhttps://reachmd.com/news/ai-and-diabetes-elevating-insulin-dosing-and-monitoring/2475548/Artificial intelligence is reshaping diabetes care, notably through enhanced insulin dosing and real-time monitoring improvements. While recent regulatory milestones and telehealth expansions encourage clinicians to integrate new tools into p
- Integrating Innovative Pharmacologic Strategies for Managing Obesity and Diabeteshttps://reachmd.com/news/integrating-innovative-pharmacologic-strategies-for-managing-obesity-and-diabetes/2475302/Obesity and diabetes frequently converge in clinical practice, creating a cycle in which escalating weight drives insulin resistance and unstable blood sugar levels exacerbate metabolic complications, underscoring the urgent need for integrat
- Income and Genetics: New Frontiers in Cardiovascular and Diabetes Healthhttps://reachmd.com/news/income-and-genetics-new-frontiers-in-cardiovascular-and-diabetes-health/2471399/Emerging research highlights the dual impacts of genetic and socioeconomic factors on cardiovascular and diabetes health, calling for integrated healthcare solutions. Genetic Markers in Cardiovascular Health Recent studies emphasize the
- Study Highlights Benefits of Spinal Manipulative Therapy in Managing Tension-Type Headacheshttps://reachmd.com/news/study-highlights-benefits-of-spinal-manipulative-therapy-in-managing-tension-type-headaches/2470684/Spinal manipulative therapy (SMT) may reduce the need for butalbital prescriptions and lower the risk of medication overuse headache (MOH) in patients with tension-type headaches (TTH), according to a retrospective study published in Health Science Reports. The research, led by Universit
- The Antiviral Tecovirimat Is Safe but Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congohttps://reachmd.com/news/the-antiviral-tecovirimat-is-safe-but-did-not-improve-clade-i-mpox-resolution-in-democratic-republic-of-the-congo/2467922/News ReleaseThursday, August 15, 2024The antiviral tecovirimat is safe but did not improve clade I mpox resolution in Democratic Republic of the Congo NIH-cosponsored study examined tecovirimat in mpox-endemic country. The
- Diabetes Management: Insights into Dietary Interventions with Protein Supplementshttps://reachmd.com/news/diabetes-management-insights-into-dietary-interventions-with-protein-supplements/2485084/A randomized crossover study found that a diabetes-specific protein supplement (DSPS) markedly reduced postprandial glycemic excursions in adults wit
- Discussions May Improve Adherence to Diabetes Medicationhttps://reachmd.com/news/discussions-may-improve-adherence-to-diabetes-medication/2462759/Credit: Pixabay/CC0 Public Domain Not taking medications exactly as prescribed is a major barrier to the treatment of diabet
- High Weekly Physical Activity Levels Linked to Lower Kidney Disease Risk in Diabetes + Overweight/Obesityhttps://reachmd.com/news/high-weekly-physical-activity-levels-linked-to-lower-kidney-disease-risk-in-diabetes-overweightobesity/2457093/Clocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney disease in overweight/obese people with type 2 diabetes, finds research published online in the
- Real-World Insights on GLP-1 Receptor Agonists vs Metformin in Adolescent Diabetes Managementhttps://reachmd.com/news/real-world-insights-on-glp-1-receptor-agonists-vs-metformin-in-adolescent-diabetes-management/2484424/GLP-1 receptor agonists produced greater BMI reduction than metformin while maintaining comparable glycemic control in adolescents with type 2 diabetes — a result that could shift treatment choice for youth with obesity-associated disease. Metformin remains the conventiona